clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Lung Diseases D008171 37 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lymphadenitis D008199 8 associated lipids
Lymphangitis D008205 4 associated lipids
Mycetoma D008271 4 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Mastoiditis D008417 2 associated lipids
Metaplasia D008679 7 associated lipids
Monoclonal Gammopathy of Undetermined Significance D008998 2 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Myocardial Infarction D009203 21 associated lipids
Myxoma D009232 1 associated lipids
Nasal Polyps D009298 26 associated lipids
Neuromuscular Diseases D009468 10 associated lipids
Nocardia Infections D009617 6 associated lipids
Endophthalmitis D009877 12 associated lipids
Psittacosis D009956 4 associated lipids
Osteomyelitis D010019 10 associated lipids
Otitis Media D010033 12 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Pain D010146 64 associated lipids
Pancreatitis D010195 10 associated lipids
Parkinson Disease D010300 53 associated lipids
Paronychia D010304 3 associated lipids
Parotid Diseases D010305 1 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Parotitis D010309 4 associated lipids
Peptic Ulcer D010437 19 associated lipids
Peptic Ulcer Hemorrhage D010438 4 associated lipids
Peptic Ulcer Perforation D010439 3 associated lipids
Periodontal Abscess D010508 2 associated lipids
Periodontal Pocket D010514 9 associated lipids
Periodontitis D010518 22 associated lipids
Pleural Diseases D010995 4 associated lipids
Pleuropneumonia D011001 3 associated lipids
Pneumonia, Mycoplasma D011019 6 associated lipids
Proteinuria D011507 30 associated lipids
Prurigo D011536 4 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Pseudomyxoma Peritonei D011553 1 associated lipids
Psoriasis D011565 47 associated lipids
Psychophysiologic Disorders D011602 3 associated lipids
Psychoses, Substance-Induced D011605 7 associated lipids
Pyelonephritis D011704 5 associated lipids
Radiation Injuries D011832 14 associated lipids
Rhabdomyolysis D012206 9 associated lipids
Rickettsia Infections D012282 5 associated lipids
Rodent Diseases D012376 4 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
VanderHeyden TR et al. Granulomatous hepatitis due to Bartonella henselae infection in an immunocompetent patient. 2012 BMC Infect. Dis. pmid:22269175
Shojaei H et al. Chronic pulmonary disease due to Mycobacterium monacense infection: the first case from Iran. 2012 Ann Lab Med pmid:22259785
Kim SY et al. Pulmonary infection caused by Mycobacterium conceptionense. 2012 Emerging Infect. Dis. pmid:22257692
[Experience with treatment of chronic polypoid rhinosinusitis using low doses of clarithromycin in the postoperative period]. 2012 Vestn. Otorinolaringol. pmid:22678641
Kim SY et al. Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea. 2012 Br J Clin Pharmacol pmid:21689141
Lotfy HM and Abdel-Monem Hagazy M Comparative study of novel spectrophotometric methods manipulating ratio spectra: an application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin. 2012 Spectrochim Acta A Mol Biomol Spectrosc pmid:22683662
Rajper S et al. Macrolide and fluoroquinolone resistance in Helicobacter pylori isolates: an experience at a tertiary care centre in Pakistan. 2012 J Pak Med Assoc pmid:23866399
Goswami S et al. Anti-Helicobacter pylori potential of artemisinin and its derivatives. 2012 Antimicrob. Agents Chemother. pmid:22687518
Cuadrado-Lavín A et al. Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial. 2012 J. Antimicrob. Chemother. pmid:22687889
Nseir W et al. Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study. 2012 Aliment. Pharmacol. Ther. pmid:22646167
Zaater MF et al. Determination and stability assessment of clarithromycin in human plasma using RP-LC with electrochemical detection. 2012 J Chromatogr Sci pmid:22647394
Bobacheva TIu [The treatment of chronic polypous rhinosinusitis in the postoperative period with low doses of clarithromycin]. 2012 Vestn. Otorinolaringol. pmid:23011378
Omoruyi OJ et al. Metachronous Mycobacterium terrae complex tenosynovitis of the hand. 2012 J Hand Surg Eur Vol pmid:22415428
Ohe M and Hashino S Successful treatment of eosinophilic gastroenteritis with clarithromycin. 2012 Korean J. Intern. Med. pmid:23269887
Breda R et al. [Mycobacterium massiliense bone infection]. 2012 Med Mal Infect pmid:22154522
Takahashi E et al. Oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza A virus. 2012 J. Virol. pmid:22896605
Chung JW et al. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial. 2012 J. Gastroenterol. Hepatol. pmid:22849546
van Ingen J et al. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. 2012 Int. J. Antimicrob. Agents pmid:22099521
Chan A et al. A case of wrist tenosynovitis caused by Mycobacterium kansasii in a renal transplant recipient. 2012 Transpl Infect Dis pmid:22822725
Patel N and Miller CD New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir. 2012 HIV AIDS (Auckl) pmid:22570576
Alzolibani AA and Zedan K Macrolides in chronic inflammatory skin disorders. 2012 Mediators Inflamm. pmid:22685371
Masekela R and Green RJ The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis. 2012 Mediators Inflamm. pmid:22570510
Vazquez-Lago JM et al. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain. 2012 Fam Pract pmid:22016323
Lee MR et al. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. 2012 J. Antimicrob. Chemother. pmid:21980068
Deguchi R et al. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. 2012 J. Gastroenterol. Hepatol. pmid:22098133
Gao M et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. 2012 Urology pmid:22100490
Fujita J and Cash HL Long-term combination treatment of azithromycin with other macrolides: a new era. 2012 Intern. Med. pmid:22687831
Zullo A et al. Role of gastritis pattern on Helicobacter pylori eradication. 2012 Intern Emerg Med pmid:22105372
Yamamoto Y et al. A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin. 2012 Intern. Med. pmid:22687847
Ivetic Tkalcevic V et al. Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. 2012 Transl Res pmid:22677362
Espinal DA et al. [Human metapneumovirus in children: first cases in Colombia]. 2012 Biomedica pmid:23242289
Cetin M et al. Clarithromycin-Induced Long QT Syndrome: A Case Report. 2012 Case Rep Med pmid:22489247
Saracino IM et al. High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. 2012 J Gastrointestin Liver Dis pmid:23256118
Kwan BY and Rabheru K Manic episode associated with clarithromycin in a patient with medically treated depression. 2012 Prim Care Companion CNS Disord pmid:22943025
Cheung JP et al. Mycobacterium marinum infection of the hand and wrist. 2012 J Orthop Surg (Hong Kong) pmid:22933682
Zong W et al. The first case of cutaneous infection with Mycobacterium parascrofulaceum. 2012 Ther Clin Risk Manag pmid:22930638
D'Elios MM et al. Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen. 2012 Expert Rev Gastroenterol Hepatol pmid:22928895
Wu TS et al. Fish tank granuloma caused by Mycobacterium marinum. 2012 PLoS ONE pmid:22911774
Ikegame S et al. Congenital cystic adenomatoid malformation in adulthood complicated by Mycobacterium celatum infection. 2012 Intern. Med. pmid:22892504
Tsay FW et al. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. 2012 J. Gastroenterol. Hepatol. pmid:21871025
Ngan LT et al. Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and -resistant strains of Helicobacter pylori. 2012 J. Agric. Food Chem. pmid:22891951
Kao SS et al. 7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan. 2012 Gastroenterol Res Pract pmid:22888337
Boyanova L et al. Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study. 2012 J. Med. Microbiol. pmid:21873378
Choi GE et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. 2012 Am. J. Respir. Crit. Care Med. pmid:22878281
Karczewska E et al. Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland. 2012 Gastroenterol Res Pract pmid:22693490
Tuchman SA et al. Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. 2012 Adv Hematol pmid:22690220
Ojetti V et al. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. 2012 Gastroenterol Res Pract pmid:22690211
Uno K et al. Rupture of renal mycotic aneurysm that developed during the treatment of streptococcal infective endocarditis and vertebral osteomyelitis. 2012 Intern. Med. pmid:22687800
Sano N et al. Comprehensive Analysis of Bacterial Flora in Postoperative Maxillary Cyst Fluid by 16S rRNA Gene and Culture Methods. 2012 ISRN Dent pmid:22685668
Sakinc T et al. Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin. 2012 BMC Res Notes pmid:23110798
Robinson P et al. Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial. 2012 Pediatr. Pulmonol. pmid:22266895
Korownyk C and Kolber MR Is quadruple therapy the new triple therapy for H pylori? 2012 Can Fam Physician pmid:22267623
Huang J et al. [A 10-day sequential therapy for eradication of Helicobacter pylori infection in children]. 2012 Zhonghua Er Ke Za Zhi pmid:23158730
Mumoli N and Cei M Clinical images: community-acquired pneumonia. 2012 CMAJ pmid:22271912
English ML et al. Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies. 2012 Antimicrob. Agents Chemother. pmid:22290969
Tatar EÇ et al. Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps. 2012 Otolaryngol Head Neck Surg pmid:22241786
Chang WJ et al. Successful salvage treatment of steroid-refractory bronchiolar COP with low-dose macrolides. 2012 Pathol. Int. pmid:22243785
Lismond A et al. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium. 2012 Int. J. Antimicrob. Agents pmid:22245497
Agarwal E et al. Efficacy of local drug delivery of 0.5% clarithromycin gel as an adjunct to non-surgical periodontal therapy in the treatment of current smokers with chronic periodontitis: a randomized controlled clinical trial. 2012 J. Periodontol. pmid:22248223
Szałek E et al. Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not? 2012 Pharmacol Rep pmid:23406766
Ogoshi T et al. A case of Good syndrome with pulmonary lesions similar to diffuse panbronchiolitis. 2012 Intern. Med. pmid:22576393
Tseng CH Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study. 2012 BMC Gastroenterol pmid:22571603
Park SK et al. Regression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori. 2012 Gut Liver pmid:22570759
Choi GE et al. Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. 2012 Antimicrob. Agents Chemother. pmid:22564831
Ivetić Tkalčević V et al. Topical azithromycin and clarithromycin inhibit acute and chronic skin inflammation in sensitized mice, with apparent selectivity for Th2-mediated processes in delayed-type hypersensitivity. 2012 Inflammation pmid:21336676
Godreuil S et al. Mycobacterium riyadhense pulmonary infection, France and Bahrain. 2012 Emerging Infect. Dis. pmid:22261434
Nakajima S et al. Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy. 2012 J. Gastroenterol. Hepatol. pmid:22486882
Sereni G et al. Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. 2012 World J. Gastroenterol. pmid:22969227
Bajaj P et al. Locally delivered 0.5% clarithromycin, as an adjunct to nonsurgical treatment in chronic periodontitis with well-controlled type 2 diabetes: a randomized controlled clinical trial. 2012 J Investig Clin Dent pmid:22976782
Pasqualetti G et al. Clarithromycin-induced rhabdomyolysis: a case report. 2012 Int J Gen Med pmid:22505827
Akelma AZ et al. Clarithromycin in treatment of acute asthma exacerbations: principles of appropriate antibiotic use. 2012 Pediatr Allergy Immunol pmid:22984834
Sachs G and Scott DR Helicobacter pylori: Eradication or Preservation. 2012 F1000 Med Rep pmid:22500191
Bataille S et al. Vancomycin-induced Henoch-Schönlein purpura: a case report. 2012 J Med Case Rep pmid:22490390
Grosso F et al. A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin. 2012 Cancer Chemother. Pharmacol. pmid:22484722
Federico A et al. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. 2012 Gastroenterology pmid:22484118
Monno R et al. Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study. 2012 APMIS pmid:22882260
Pandya GJ et al. Unilateral lobar pulmonary edema. 2012 J Assoc Physicians India pmid:23547417
Ablanedo-Terrazas Y et al. Palatal Actinomycosis and Kaposi Sarcoma in an HIV-Infected Subject with Disseminated Mycobacterium avium-intracellulare Infection. 2012 Case Rep Med pmid:22481952
Fakheri H et al. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial. 2012 Helicobacter pmid:22221615
Georgopoulos S et al. Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece. 2012 Helicobacter pmid:22221616
Komatsu S et al. Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells. 2012 Int. J. Oncol. pmid:22200786
Buyck JM et al. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. 2012 Clin. Infect. Dis. pmid:22573850
Scheel AH et al. Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report. 2012 Diagn Pathol pmid:22420484
Brüning J et al. Erythromycin A dimethyl sulfoxide disolvate 1.43-hydrate. 2012 Acta Crystallogr Sect E Struct Rep Online pmid:22412590
Noguchi S et al. Clarithromycin monohydrate: a synchrotron X-ray powder study. 2012 Acta Crystallogr Sect E Struct Rep Online pmid:22412567
Karne SS et al. Mycobacterium avium-intracellulare brain abscess in HIV-positive patient. 2012 Ann Indian Acad Neurol pmid:22412276
Yanai A et al. Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. 2012 World J Gastrointest Pharmacol Ther pmid:22408744
Yeboah J and Sharma OP Co-existence of Crohn's disease, sarcoidosis and malignant lymphomas. 2012 JRSM Short Rep pmid:22393471
Martins TG et al. Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection. 2012 PLoS ONE pmid:22393444
Legendre DP et al. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. 2012 Pharmacotherapy pmid:22392826
Li Y et al. A data-driven predictive approach for drug delivery using machine learning techniques. 2012 PLoS ONE pmid:22384063
Hong SJ The Role of Mycoplasma pneumoniae Infection in Asthma. 2012 Allergy Asthma Immunol Res pmid:22379599
Cronnolly B and Pegrum H Fentanyl-clarithromycin interaction. 2012 BMJ Case Rep pmid:22778456
Berti AD et al. Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics. 2012 Antimicrob. Agents Chemother. pmid:22802248
Khavinson VKh et al. Peptidergic regulation of expression of genes encoding antioxidant and anti-inflammatory proteins. 2012 Bull. Exp. Biol. Med. pmid:22803148
Molina-Infante J et al. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains. 2012 Helicobacter pmid:22759326
Kongchayanun C et al. Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand. 2012 Helicobacter pmid:22759328
Nguyen TV et al. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. 2012 Helicobacter pmid:22759333
Siqueira JF et al. Pyrosequencing as a tool for better understanding of human microbiomes. 2012 J Oral Microbiol pmid:22279602
O'Brien DP et al. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. 2012 PLoS Negl Trop Dis pmid:22272368